Drugs / CMV Specific Cytotoxic T Lymphocytes (CTL)
CMV Specific Cytotoxic T Lymphocytes (CTL)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00990496 | Sep 2009 → Oct 2010 | glioblastoma | Milton S. Hershey Medical Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMV Specific Cytotoxic T Lymphocytes (CTL) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00990496 ↗ |
| Modality | Cell therapy | “allogeneic, CMV specific cytotoxic T cells (CTL)” NCT00990496 ↗ |